Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infocom Corporation is a leading Japanese information technology company that provides specialized software and services for the healthcare and life sciences sectors. The company's Life Science division is a major provider of drug discovery informatics, offering tools for chemical management, bioinformatics, and molecular modeling to pharmaceutical companies and research institutions. Infocom also develops and maintains clinical trial management systems (CTMS) and hospital information systems that streamline medical data and research workflows. In 2024, the company was acquired by Blackstone from the Teijin Group in a deal valued at approximately $1.7 billion, reflecting its strong position in the digital health market. While Infocom also operates a significant digital entertainment business, its healthcare IT solutions remain a cornerstone of its enterprise value.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infocom.